Low-priced, exit-prevention medicines to be waivered from obligatory small package system in August

The Korea Food and Drug Administration plans to revamp the controversial small package system, to this effect that low-priced drugs of less than 50 won in price tag and/or exit-prevention medicines should be excluded from the current small drug package obligation from next month.

The KFDA said these drugs have been big headaches for pharmaceutical manufacturers as many firms have found it di...